ArticleInternational journal of clinical and experimental pathology2015
Subependymoma with extensive microcystic transformation: a case report.
Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subependymomas are benign tumors that occur predominantly in the ventricular system. We described a case of a 44-year-old female with a large subtentorial mass which compressed the brain stem and fourth ventricle. Complete surgical excision of the tumor was achieved. The tumor composed of collections of cytologically bland cells with round to oval nuclei set within wide expanses of a delicate fibrillar matrix, and extensive microcystic changes were found. The tumor demonstrated positive staining with GFAP and S-100 protein, and did not stain with antibodies to Neu-N or Progesterone receptor, patchy expression of Epithelial Membrane Antigen. An MIB-1 labeling was lower than 1%. The tumor was totally resected and didn't recur after the initial surgery.
Indexed as
Identifiers
25973126PMC4396238What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.